首页> 外文期刊>American Journal of Translational Research >An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: a study protocol
【24h】

An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: a study protocol

机译:新型伤口愈合疗法与新型医学基质和成纤维细胞生长因子联合治疗慢性皮肤溃疡的探索性临床试验:一项研究方案

获取原文
           

摘要

BackgroundChronic skin ulcers such as diabetic ulcers and venous leg ulcers are increasing and are a costly problem in health care. We have developed a novel artificial dermis, collagen/gelatin sponge (CGS), that is capable of the sustained release of basic fibroblast growth factor (bFGF) for more than 10 days. The objective of this study was to investigate the safety and efficacy of CGS impregnated with bFGF in the treatment of chronic skin ulcers. Methods/.
机译:背景技术慢性皮肤溃疡,例如糖尿病性溃疡和静脉曲张性溃疡正在增加,并且在卫生保健中是昂贵的问题。我们开发了一种新型的人造真皮,胶原蛋白/明胶海绵(CGS),能够持续释放碱性成纤维细胞生长因子(bFGF)10天以上。这项研究的目的是研究用bFGF浸渍的CGS在治疗慢性皮肤溃疡中的安全性和有效性。方法/。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号